Alcanza Clinical Research

Founded in December 2021, Alcanza Clinical Research was started by Martis as a leading clinical research site network providing high quality execution and removing barriers to increase patient accessibility for clinical trials. The Company provides full-scale Phase I-IV capabilities across multiple therapeutic areas and maintains a diverse client base of blue-chip pharma sponsors and CROs.

Investment Rationale

  • Strong market tailwinds in pharma services outsourcing with recession resilient dynamics
  • Significant benefits of scale and opportunity for consolidation
  • Opportunity to implement platform-wide operational best practices

Key Value Add Areas

  • Team & Board
  • Strategic Planning
  • Finance & Operations
  • Technology Infrastructure
  • M&A
  • Monitoring & Reporting


Methuen, MA

Investment Date:

Dec 2021


Services & Outsourcing